Original Literature | Model OverView |
---|---|
Publication
Title
Signals and receptors involved in recruitment of inflammatory cells.
Affiliation
Laboratory of Molecular Immunoregulation, NCI, National Institutes of Health,Frederick, Maryland 21702-1201, USA.
Abstract
PMID
7744810
|
Entity
PLD
--
MO000000064
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m47
10
infinite
0
TRANSPATH | MO000000064 |
--
PKC
--
MO000000104
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m92
10
infinite
0
TRANSPATH | MO000000104 |
--
IL-1
--
MO000000214
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m185
10
infinite
0
TRANSPATH | MO000000214 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
trimeric G-proteins((Galpha:GDP):Gbeta:Ggamma)
--
MO000000315
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m250
10
infinite
0
TRANSPATH | MO000000315 |
--
IFNgamma
--
MO000016665
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1639
10
infinite
0
InterPro | IPR002069 |
TRANSPATH | MO000016665 |
--
IL-8
--
MO000017264
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2120
10
infinite
0
InterPro | IPR002473 |
TRANSPATH | MO000017264 |
--
PLCbeta2
--
MO000018975
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3586
10
infinite
0
InterPro | IPR000008 |
TRANSPATH | MO000018975 |
--
ENA-78
--
MO000019827
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m4356
10
infinite
0
InterPro | IPR002473 |
TRANSPATH | MO000019827 |
--
LPS
--
MO000042409
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m157177
10
infinite
0
TRANSPATH | MO000042409 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
Lectin
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
csml-variable:Double
m12
0
infinite
0
--
Phorbol 12-myristate
--
e13
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
13-acetate
--
e14
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m14
0
infinite
0
--
Hepatitis B virus protein X
--
e15
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m15
0
infinite
0
--
Dexamethasone
--
e16
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
IL-1
--
e17
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m17
0
infinite
0
--
Interferon-beta
--
e18
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m18
0
infinite
0
--
GRObeta
--
e19
cso30:c:mRNA
cso30:i:CC_Nucleolus
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
GROgamma
--
e20
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m20
0
infinite
0
--
ENA-78
--
e21
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m21
0
infinite
0
--
IP-10
--
e23
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
MIP-1alpha
--
e24
cso30:c:mRNA
cso30:i:CC_Nucleolus
--
csml-variable:Double
m24
0
infinite
0
--
GMCSF
--
e25
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
IL-8R
--
e26
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m26
0
infinite
0
--
C5aR
--
e27
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m27
0
infinite
0
--
fMLPR
--
e28
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m28
0
infinite
0
--
GCSF
--
e29
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IL-8RA
--
e30
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m30
0
infinite
0
--
IL-8:IL-8RA
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m31
0
infinite
0
--
IL-8RB
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
IL-8:IL-8RB
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m33
0
infinite
0
--
Ligand
--
e34
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m34
0
infinite
0
--
GPCR:Ligand
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
trimeric G-proteins{active}
--
e36
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m36
10
infinite
0
TRANSPATH | MO000000315 |
--
G-protein alpha:GTP
--
e37
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
G-protein beta:gamma
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m38
0
infinite
0
--
trimeric G-proteins{active}((Galpha:GTP):Gbeta:Ggamma)
--
e39
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m39
10
infinite
0
TRANSPATH | MO000000315 |
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
PLCbeta2{active}
--
e41
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m41
10
infinite
0
InterPro | IPR000008 |
TRANSPATH | MO000018975 |
--
IP3
--
e42
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
DG
--
e43
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
Calcium
--
e44
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
PKC{active}
--
e45
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m45
10
infinite
0
TRANSPATH | MO000000104 |
--
PLD{active}
--
e47
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m48
10
infinite
0
TRANSPATH | MO000000064 |
--
Phosphatidic acid
--
e48
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m49
0
infinite
0
--
PAF
--
e49
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m63
0
infinite
0
--
IL-8
--
e5
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
Bacteria
--
e6
cso30:c:Cell
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
LTB4
--
e63
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m64
0
infinite
0
--
C5a:C5aR
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
MAP Kinase
--
e66
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m67
0
infinite
0
--
MAP Kinase{active}
--
e67
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m68
0
infinite
0
--
csml-variable:Double
m69
0
infinite
0
--
NF-IL-6
--
e69
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
Il-8 gene: RelaA:NF-IL-6
--
e70
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m71
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c2 : 1
stoichiometry:c22 : 1
stoichiometry:c3 : 1
m12*0.1
nodelay
--
0
PMID: 7744810,7584498,3260265 Numerous exogenous agents and endogenous proinflammatory stimulants, such as endotoxin, lectins, hypoxia, viruses, bacteria, IL-1, and TNF-alpha, stimulate IL-8 production in a wide variety of cell types,by stabilization of IL-8 mRNA as well as by activation of IL-8 gene transcription PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c28 : 1
m15*0.1
nodelay
--
0
PMID: 7744810 Analysis of the IL-8 promoter showed that the sequences between positions -91 and -71 contain the NF-KappaB-binding site and the NF-IL-6 (or C/EBP) site and are sufficient for the induction of IL-8 gene transcription by LPS, IL-1, TNF-alpha, phorbol 12-myristate 13-acetate, or hepatitis B virus protein X. PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
1.0*0.1
nodelay
--
0
PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
1.0*0.1
nodelay
--
0
PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8.
p13
p13
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m230*0.1
nodelay
--
0
PMID: 7744810,2217207 IL-1 and TNF-alpha stimulate the expression of many of the alpha-chemokines including GROalpha, GRObeta (MIP-2alpha), and GROgamma (MIP-2 beta) in monocytes, fibroblasts, endothelial cells, and mammary epithelial cells through NF-KappaB sites in their promoters
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m230*0.1
nodelay
--
0
PMID: 7744810,2217207 IL-1 and TNF-alpha stimulate the expression of many of the alpha-chemokines including GROalpha, GRObeta (MIP-2alpha), and GROgamma (MIP-2 beta) in monocytes, fibroblasts, endothelial cells, and mammary epithelial cells through NF-KappaB sites in their promoters
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m230*0.1
nodelay
--
0
PMID: 7744810,2217207 IL-1 and TNF-alpha stimulate the expression of many of the alpha-chemokines including GROalpha, GRObeta (MIP-2alpha), and GROgamma (MIP-2 beta) in monocytes, fibroblasts, endothelial cells, and mammary epithelial cells through NF-KappaB sites in their promoters
p13
p16
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m185*0.1
nodelay
--
0
PMID: 7744810,2217207 IL-1 and TNF-alpha stimulate the expression of many of the alpha-chemokines including GROalpha, GRObeta (MIP-2alpha), and GROgamma (MIP-2 beta) in monocytes, fibroblasts, endothelial cells, and mammary epithelial cells through NF-KappaB sites in their promoters
p13
p17
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
m185*0.1
nodelay
--
0
PMID: 7744810,2217207 IL-1 and TNF-alpha stimulate the expression of many of the alpha-chemokines including GROalpha, GRObeta (MIP-2alpha), and GROgamma (MIP-2 beta) in monocytes, fibroblasts, endothelial cells, and mammary epithelial cells through NF-KappaB sites in their promoters
p13
p18
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m185*0.1
nodelay
--
0
PMID: 7744810,2217207 IL-1 and TNF-alpha stimulate the expression of many of the alpha-chemokines including GROalpha, GRObeta (MIP-2alpha), and GROgamma (MIP-2 beta) in monocytes, fibroblasts, endothelial cells, and mammary epithelial cells through NF-KappaB sites in their promoters
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m4356*0.1
nodelay
--
0
PMID: 7744810,7584498,7929219,8083342 ENA-78, one of the neutrophil attractant chemokines, is produced and secreted by epithelial cells in response to IL-1beta or TNF-alpha, along with IL-8, GROalpha, and GROgamma.
p2
p2
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c20 : 1
stoichiometry:c4 : 1
m185*0.1
nodelay
--
0
PMID: 7744810,7584498,3260265 Numerous exogenous agents and endogenous proinflammatory stimulants, such as endotoxin, lectins, hypoxia, viruses, bacteria, IL-1, and TNF-alpha, stimulate IL-8 production in a wide variety of cell types,by stabilization of IL-8 mRNA as well as by activation of IL-8 gene transcription PMID: 7744810 Analysis of the IL-8 promoter showed that the sequences between positions -91 and -71 contain the NF-KappaB-binding site and the NF-IL-6 (or C/EBP) site and are sufficient for the induction of IL-8 gene transcription by LPS, IL-1, TNF-alpha, phorbol 12-myristate 13-acetate, or hepatitis B virus protein X. PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8. PMID: 7744810,8175759 However, dexamethasone also suppresses IL-1-induced IL-8 production through the NF-kappaB site
p20
p20
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c50 : 1
stoichiometry:c47 : 1
m21*m230*0.1
nodelay
--
0
PMID: 7744810,7584498,7929219,8083342 ENA-78, one of the neutrophil attractant chemokines, is produced and secreted by epithelial cells in response to IL-1beta or TNF-alpha, along with IL-8, GROalpha, and GROgamma
p20
p21
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m1591*m21*0.1
nodelay
--
0
PMID: 7744810,7584498,7929219,8083342 ENA-78, one of the neutrophil attractant chemokines, is produced and secreted by epithelial cells in response to IL-1beta or TNF-alpha, along with IL-8, GROalpha, and GROgamma
p22
p22
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c56 : 1
stoichiometry:c55 : 1
m1639*0.1
nodelay
--
0
PMID: 7744810,8454640 IFN-gamma induces IP-10 expression through an ISRE element present in the region flanking the transcription start site PMID: 7744810,8051417 IL-4 can inhibit IFN-gamma induction by activation of a negative regulator that competes for the ISRE site
p23
p23
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m1639*0.1
nodelay
--
0
PMID: 7744810,8355682 NF-IL-6 (C/EPB), NF-KappaB, and c-Ets sites have been identified in the promoter for MIP-1alpha
p23
p24
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m157177*0.1
nodelay
--
0
PMID: 7744810,8355682 NF-IL-6 (C/EPB), NF-KappaB, and c-Ets sites have been identified in the promoter for MIP-1alpha
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
1.0*0.1
nodelay
--
0
PMID: 7744810 Studies of the regulation of neutrophil expression of CCRs show that a 30-min incubation of neutrophils with granulocyte-macrophage colony-stimulating factor down-regulates the expression of IL-8R and C5a receptor (C5aR) and up-regulates fMLP receptor (fMLPR) expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
1.0*0.1
nodelay
--
0
PMID: 7744810 Studies of the regulation of neutrophil expression of CCRs show that a 30-min incubation of neutrophils with granulocyte-macrophage colony-stimulating factor down-regulates the expression of IL-8R and C5a receptor (C5aR) and up-regulates fMLP receptor (fMLPR) expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m25*0.1
nodelay
--
0
PMID: 7744810 Studies of the regulation of neutrophil expression of CCRs show that a 30-min incubation of neutrophils with granulocyte-macrophage colony-stimulating factor down-regulates the expression of IL-8R and C5a receptor (C5aR) and up-regulates fMLP receptor (fMLPR) expression
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m29*0.1
nodelay
--
0
PMID: 7744810 In addition, in vitro incubation of neutrophils with granulocyte colony-stimulating factor enhances, whereas LPS inhibits, the expression of IL-8R mRNA, IL-8 binding, and chemotactic responses by neutrophils
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
1.0*0.1
nodelay
--
0
PMID: 7744810 In addition, in vitro incubation of neutrophils with granulocyte colony-stimulating factor enhances, whereas LPS inhibits, the expression of IL-8R mRNA, IL-8 binding, and chemotactic responses by neutrophils
p2
p3
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c5 : 1
stoichiometry:c21 : 1
stoichiometry:c33 : 1
stoichiometry:c6 : 1
m230*0.1
nodelay
--
0
PMID: 7744810,7584498,3260265 Numerous exogenous agents and endogenous proinflammatory stimulants, such as endotoxin, lectins, hypoxia, viruses, bacteria, IL-1, and TNF-alpha, stimulate IL-8 production in a wide variety of cell types,by stabilization of IL-8 mRNA as well as by activation of IL-8 gene transcription PMID: 7744810 Analysis of the IL-8 promoter showed that the sequences between positions -91 and -71 contain the NF-KappaB-binding site and the NF-IL-6 (or C/EBP) site and are sufficient for the induction of IL-8 gene transcription by LPS, IL-1, TNF-alpha, phorbol 12-myristate 13-acetate, or hepatitis B virus protein X. PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8. PMID: 7744810,8035808 Interferon- beta also appears to regulate inflammatory cytokine transcription as it inhibits TNF-alpha-induced IL-8 gene expression at the transcriptional level via the NF-KappaB site
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m157177*0.1
nodelay
--
0
PMID: 7744810 In contrast, LPS up-regulates the expression of neutrophil fMLP receptors by increasing gene transcription
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
stoichiometry:c75 : 1
m2120*m30*0.1
nodelay
--
0
PMID: 7744810 Studies on IL-8RA and IL-8RB show that although both receptors bind IL-8 with similar affinities, the ligand-receptor interaction to each of the receptors is mediated through different regions of IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m32*m2120*0.1
nodelay
--
0
PMID: 7744810 Studies on IL-8RA and IL-8RB show that although both receptors bind IL-8 with similar affinities, the ligand-receptor interaction to each of the receptors is mediated through different regions of IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m34*m249*0.1
nodelay
--
0
PMID: 7744810 The best characterized signal transduction pathway of G protein-coupled receptors starts with ligand binding, followed by activation of a heterotrimeric G protein.
p34
p34
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m35*m250*0.1
nodelay
--
0
PMID: 7744810 The best characterized signal transduction pathway of G protein-coupled receptors starts with ligand binding, followed by activation of a heterotrimeric G protein.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m36*0.1
nodelay
--
0
PMID: 7744810 An exchange occurs in the alpha subunit of the G protein from a GDP- to a GTP-bound state, resulting in a dissociation of the alpha subunit from the beta-gamma subunits
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m39*0.1
nodelay
--
0
PMID: 7744810 An exchange occurs in the alpha subunit of the G protein from a GDP- to a GTP-bound state, resulting in a dissociation of the alpha subunit from the beta-gamma subunits
p37
p37
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m37*m1237*0.1
nodelay
--
0
PMID: 7744810 The free alpha subunit can activate both phospholipase C (PLCbeta) 1 and PLCbeta2, whereas the free beta-gamma complex activates preferentially PLCbeta2.
p37
p38
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c93 : 1
m37*m3586*0.1
nodelay
--
0
PMID: 7744810 The free alpha subunit can activate both phospholipase C (PLCbeta) 1 and PLCbeta2, whereas the free beta-gamma complex activates preferentially PLCbeta2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c97 : 1
stoichiometry:c98 : 1
stoichiometry:c99 : 1
m41*m290229*0.1
nodelay
--
0
PMID: 7744810 The activation of PLCs results in hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to generate two second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DG).
p4
p4
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c25 : 1
stoichiometry:c8 : 1
m157177*0.1
nodelay
--
0
PMID: 7744810 Analysis of the IL-8 promoter showed that the sequences between positions -91 and -71 contain the NF-KappaB-binding site and the NF-IL-6 (or C/EBP) site and are sufficient for the induction of IL-8 gene transcription by LPS, IL-1, TNF-alpha, phorbol 12-myristate 13-acetate, or hepatitis B virus protein X. PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m40*m290229*0.1
nodelay
--
0
PMID: 7744810 The activation of PLCs results in hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to generate two second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DG).
p37
p41
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m38*m3586*0.1
nodelay
--
0
PMID: 7744810 The free alpha subunit can activate both phospholipase C (PLCbeta) 1 and PLCbeta2, whereas the free beta-gamma complex activates preferentially PLCbeta2.
p42
p42
cso30:i:ME_ChangeInMaterialConcentration
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m42*0.1
nodelay
--
0
PMID: 7744810,1314560,8304236,1902986 IP3 mobilizes Ca2+ from intracellular stores leading to a transient rise in [Ca2+], whereas DG stimulates PKC
p43
p43
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m43*m92*0.1
nodelay
--
0
PMID: 7744810,1314560,8304236,1902986 IP3 mobilizes Ca2+ from intracellular stores leading to a transient rise in [Ca2+], whereas DG stimulates PKC
p44
p44
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
stoichiometry:c112 : 1
stoichiometry:c115 : 1
stoichiometry:c120 : 1
m45*m119*m44*0.1
nodelay
--
0
PMID: 7744810,2104616 Moreover, activation of PKC and elevation in cytosolic Ca2+ can thereafter induce PLC and phospholipase D (PLD) to yield DG and phosphatidic acid, respectively, resulting in a positive feedback loop
p44
p45
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c118 : 1
stoichiometry:c117 : 1
stoichiometry:c119 : 1
stoichiometry:c121 : 1
m44*m47*m45*0.1
nodelay
--
0
PMID: 7744810,2104616 Moreover, activation of PKC and elevation in cytosolic Ca2+ can thereafter induce PLC and phospholipase D (PLD) to yield DG and phosphatidic acid, respectively, resulting in a positive feedback loop
p46
p46
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c123 : 1
stoichiometry:c124 : 1
m2120*m47*0.1
nodelay
--
0
PMID: 7744810,7949145 PLD activation was also shown to be induced by IL-8, fMLP, C5a, PAF, and LTB4.
p47
p47
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c165 : 1
stoichiometry:c166 : 1
stoichiometry:c167 : 1
m69*m70*m166*0.1
nodelay
--
0
PMID: 7744810,8413306,8207232 Studies on Jurkat and HeLa cells showed that the IL-8 gene is regulated by a cooperative binding to the DNA of the C/EBP binding-protein (NF-IL-6) and the NF-B-binding protein (RelA)
p46
p48
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m138859*m47*0.1
nodelay
--
0
PMID: 7744810,7949145 PLD activation was also shown to be induced by IL-8, fMLP, C5a, PAF, and LTB4.
p46
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m12280*m47*0.1
nodelay
--
0
PMID: 7744810,7949145 PLD activation was also shown to be induced by IL-8, fMLP, C5a, PAF, and LTB4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c23 : 1
stoichiometry:c10 : 1
m6*0.1
nodelay
--
0
PMID: 7744810,7584498,3260265 Numerous exogenous agents and endogenous proinflammatory stimulants, such as endotoxin, lectins, hypoxia, viruses, bacteria, IL-1, and TNF-alpha, stimulate IL-8 production in a wide variety of cell types,by stabilization of IL-8 mRNA as well as by activation of IL-8 gene transcription PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8.
p46
p50
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
stoichiometry:c133 : 1
m63*m47*0.1
nodelay
--
0
PMID: 7744810,7949145 PLD activation was also shown to be induced by IL-8, fMLP, C5a, PAF, and LTB4.
p46
p51
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
m64*m47*0.1
nodelay
--
0
PMID: 7744810,7949145 PLD activation was also shown to be induced by IL-8, fMLP, C5a, PAF, and LTB4.
p52
p52
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c138 : 1
stoichiometry:c139 : 1
m2120*m92*0.1
nodelay
--
0
PMID: 7744810,8144937,8034695,8376383 Activation of PKC and a number of additional serine/threonine kinases was demonstrated in response to IL-8, fMLP, MCP-1, MCP-2, and MCP-3
p52
p53
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c140 : 1
stoichiometry:c141 : 1
stoichiometry:c142 : 1
m138859*m92*0.1
nodelay
--
0
PMID: 7744810,8144937,8034695,8376383 Activation of PKC and a number of additional serine/threonine kinases was demonstrated in response to IL-8, fMLP, MCP-1, MCP-2, and MCP-3
p52
p54
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c143 : 1
stoichiometry:c144 : 1
stoichiometry:c145 : 1
m2133*m92*0.1
nodelay
--
0
PMID: 7744810,8144937,8034695,8376383 Activation of PKC and a number of additional serine/threonine kinases was demonstrated in response to IL-8, fMLP, MCP-1, MCP-2, and MCP-3
p52
p55
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c146 : 1
stoichiometry:c147 : 1
stoichiometry:c148 : 1
m4422*m92*0.1
nodelay
--
0
PMID: 7744810,8144937,8034695,8376383 Activation of PKC and a number of additional serine/threonine kinases was demonstrated in response to IL-8, fMLP, MCP-1, MCP-2, and MCP-3
p52
p56
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c150 : 1
stoichiometry:c151 : 1
m4426*m92*0.1
nodelay
--
0
PMID: 7744810,8144937,8034695,8376383 Activation of PKC and a number of additional serine/threonine kinases was demonstrated in response to IL-8, fMLP, MCP-1, MCP-2, and MCP-3
p57
p57
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c153 : 1
stoichiometry:c154 : 1
m12280*m6571*0.1
nodelay
--
0
--
p58
p58
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c156 : 1
stoichiometry:c157 : 1
m65*m120*0.1
nodelay
--
0
PMID: 7744810,8090790 Buhl et al,have proposed a model for the C5aR-induced signal transduction network in human polymorphonuclear leukocytes, proceeding from PLC through PKC to stimulation of the MAP kinase pathway.
p58
p59
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c160 : 1
stoichiometry:c159 : 1
m92*m66*0.1
nodelay
--
0
PMID: 7744810,8090790 Buhl et al,have proposed a model for the C5aR-induced signal transduction network in human polymorphonuclear leukocytes, proceeding from PLC through PKC to stimulation of the MAP kinase pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m5*0.1
nodelay
--
0
PMID: 7744810,7584498,3260265 Numerous exogenous agents and endogenous proinflammatory stimulants, such as endotoxin, lectins, hypoxia, viruses, bacteria, IL-1, and TNF-alpha, stimulate IL-8 production in a wide variety of cell types,by stabilization of IL-8 mRNA as well as by activation of IL-8 gene transcription
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c161 : 1
stoichiometry:c162 : 1
stoichiometry:c163 : 1
m45*m67*0.1
nodelay
--
0
PMID: 7744810,8090790 Buhl et al,have proposed a model for the C5aR-induced signal transduction network in human polymorphonuclear leukocytes, proceeding from PLC through PKC to stimulation of the MAP kinase pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c24 : 1
stoichiometry:c14 : 1
m11*0.1
nodelay
--
0
PMID: 7744810,7584498,3260265 Numerous exogenous agents and endogenous proinflammatory stimulants, such as endotoxin, lectins, hypoxia, viruses, bacteria, IL-1, and TNF-alpha, stimulate IL-8 production in a wide variety of cell types,by stabilization of IL-8 mRNA as well as by activation of IL-8 gene transcription PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c26 : 1
stoichiometry:c16 : 1
m13*0.1
nodelay
--
0
PMID: 7744810 Analysis of the IL-8 promoter showed that the sequences between positions -91 and -71 contain the NF-KappaB-binding site and the NF-IL-6 (or C/EBP) site and are sufficient for the induction of IL-8 gene transcription by LPS, IL-1, TNF-alpha, phorbol 12-myristate 13-acetate, or hepatitis B virus protein X. PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c27 : 1
stoichiometry:c18 : 1
m14*0.1
nodelay
--
0
PMID: 7744810 Analysis of the IL-8 promoter showed that the sequences between positions -91 and -71 contain the NF-KappaB-binding site and the NF-IL-6 (or C/EBP) site and are sufficient for the induction of IL-8 gene transcription by LPS, IL-1, TNF-alpha, phorbol 12-myristate 13-acetate, or hepatitis B virus protein X. PMID: 7744810 Glucocorticoids, such as dexamethasone, are potent immunomodulating anti-inflammatory agents that have a marked inhibitory effect on the gene transcription of several proinflammatory cytokines including IL-1, TNF-alpha, and IL-8.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--